Catalent
CTLT
#1755
Rank
โ‚น1.031 T
Marketcap
โ‚น5,685
Share price
0.00%
Change (1 day)
19.95%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -โ‚น527.16

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น566.86. In 2023 the company made an earnings per share (EPS) of -โ‚น608.95 a decrease over its 2022 EPS that were of โ‚น203.28.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น527.16-13.43%
2023-โ‚น608.95-399.56%
2022โ‚น203.28-30.58%
2021โ‚น292.8479.67%
2020โ‚น162.98114.12%
2019โ‚น76.12-15%
2018โ‚น89.5575.44%
2017โ‚น51.04-22.97%
2016โ‚น66.27-59.56%
2015โ‚น163.88282.05%
2014โ‚น42.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น29.55-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น67.16-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
-โ‚น533.73-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
-โ‚น132.54-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA